Social Starts — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Probius develops Quantum Electrochemical Spectroscopy (QES), a label- and reagent-free electrochemical sensing technology that detects and quantifies thousands of analytes—proteins, metabolites, and cells—from microliter-scale biological samples in about 30 minutes.
AI & Machine LearningBiotechDeep TechHardwareHealthtechSemiconductorsFremont, US
Chaitanya Gupta(Executive Officer, Director)inEmmanuel Quevy(Co-founder & CEO)in
Co-investorsCota CapitalHeuristic Capital PartnersJoyance PartnersQubits VenturesSilicon CatalystTSVC
Ruby Bio develops biosynthesis technology and scale-up solutions for specialty chemicals, biofuels, and alternative proteins.
BiotechDeep TechFoodTechNew MaterialsSan Carlos, US
Charlie Silver(CEO/Co-founder)inPavan(Co-founder)Kevin Yanos(Executive Officer)Mark(Executive (role not specified))Ana(Executive (role not specified))Harshal(Executive (role not specified))
Co-investorsAlumni VenturesEarth Venture CapitalFusionJoyance PartnersKicker VenturesThe Venture Collective+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.







